(GMAB) Genmab - Performance -38.9% in 12m
Compare GMAB with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-37.10%
#58 in Group
Rel. Strength
16.63%
#6370 in Universe
Total Return 12m
-38.85%
#81 in Group
Total Return 5y
-12.64%
#43 in Group
P/E 10.9
43th Percentile in Group
P/E Forward 11.1
44th Percentile in Group
PEG 1.06
83th Percentile in Group
FCF Yield 10.0%
98th Percentile in Group
12m Total Return: GMAB (-38.9%) vs XBI (-11%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| ABBV NYSE AbbVie |
-2.97% | 17.7% | 234% | 84.1 | 16.4 | 0.42 | -49.6% | -19% |
| UTHR NASDAQ United Therapeutics |
0.72% | 36.6% | 226% | 13 | 11.3 | 1.43 | 83.8% | 78.5% |
| HLN NYSE Haleon |
-3.97% | 23.4% | 39.7% | 25.6 | 20.9 | 1.85 | -38.6% | -24.4% |
| AMGN NASDAQ Amgen |
-1.63% | 14.1% | 68.5% | 40.5 | 14.8 | 1.04 | -18.8% | -20% |
| LONN SW Lonza |
-7.89% | 0.58% | 37% | 60.5 | 31.8 | 1.16 | 12.6% | -10.3% |
| NBIX NASDAQ Neurocrine Biosciences |
-5.39% | -21.4% | 18.7% | 33.6 | 22.8 | 0.27 | 61.5% | 31.6% |
| BIM PA Biomerieux |
1.3% | 15.8% | 12.1% | 31.4 | 25.8 | 1.47 | -47.6% | -26.9% |
| KMDA NASDAQ Kamada |
1.65% | 24.1% | 14.1% | 27 | 25 | 1 | 58.7% | 15% |
Performance Comparison: GMAB vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for GMAB
| Total Return (including Dividends) | GMAB | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -21.99% | -5.85% | -3.01% |
| 3 Months | -16.69% | -11.95% | -3.15% |
| 12 Months | -38.85% | -11.00% | 10.19% |
| 5 Years | -12.64% | 0.65% | 129.24% |
| Trend Score (consistency of price movement) | GMAB | XBI | S&P 500 |
| 1 Month | -83.0% | -59.8% | -5.5% |
| 3 Months | -41.7% | -70.5% | -58.4% |
| 12 Months | -89.1% | -6.9% | 84.1% |
| 5 Years | -38.6% | -50% | 84.4% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #153 | -17.1% | -19.6% |
| 3 Month | #68 | -5.38% | -14.0% |
| 12 Month | #80 | -31.3% | -44.5% |
| 5 Years | #49 | -13.2% | -61.9% |
FAQs
Does GMAB Genmab outperforms the market?
No,
over the last 12 months GMAB made -38.85%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.00%.
Over the last 3 months GMAB made -16.69%, while XBI made -11.95%.
Over the last 3 months GMAB made -16.69%, while XBI made -11.95%.
Performance Comparison GMAB vs Indeces and Sectors
GMAB vs. Indices GMAB is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -5.22% | -19.0% | -19.8% | -49.0% |
| US NASDAQ 100 | QQQ | -4.24% | -17.9% | -19.1% | -47.5% |
| US Dow Jones Industrial 30 | DIA | -5.42% | -19.9% | -20.8% | -48.4% |
| German DAX 40 | DAX | -3.92% | -18.6% | -36.6% | -60.5% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -4.93% | -22.2% | -4.60% | -48.0% |
| Hongkong Hang Seng | HSI | -7.19% | -24.8% | -10.6% | -56.2% |
| India NIFTY 50 | INDA | -6.25% | -29.9% | -9.48% | -39.6% |
| Brasil Bovespa | EWZ | -5.33% | -30.3% | -11.8% | -27.1% |
GMAB vs. Sectors GMAB is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -3.68% | -18.2% | -27.9% | -58.1% |
| Consumer Discretionary | XLY | -5.98% | -18.2% | -23.2% | -52.9% |
| Consumer Staples | XLP | -8.01% | -20.2% | -20.7% | -49.9% |
| Energy | XLE | -6.31% | -30.0% | -25.4% | -39.7% |
| Financial | XLF | -5.70% | -19.3% | -32.0% | -61.1% |
| Health Care | XLV | -5.64% | -18.8% | -15.1% | -40.5% |
| Industrial | XLI | -5.53% | -21.3% | -19.1% | -47.4% |
| Materials | XLB | -6.32% | -22.5% | -11.7% | -34.9% |
| Real Estate | XLRE | -7.26% | -19.3% | -16.7% | -52.2% |
| Technology | XLK | -4.09% | -18.0% | -14.7% | -40.9% |
| Utilities | XLU | -8.51% | -22.8% | -19.0% | -64.1% |
| Aerospace & Defense | XAR | -4.62% | -23.3% | -23.8% | -59.8% |
| Biotech | XBI | -0.66% | -16.1% | -2.13% | -27.9% |
| Homebuilder | XHB | -5.72% | -22.1% | -0.45% | -31.2% |
| Retail | XRT | -7.52% | -21.5% | -15.8% | -34.1% |